Robert Uger

Robert Uger appears in our data through filings on Trillium Therapeutics Inc. shares, published by SEC (Form 4). Between 7 January 2021 and 7 July 2021, the trades on record add up to 20 filings.

On the market, this insider has only sold: 10 sales, €266k in total. The rest of the record consists of 10 option exercises.

The newest entry dates from 8 July 2021: an open-market sale of €22k, in Trillium Therapeutics Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.